Biomarker services for translational oncology
Add assays, molecular profiling and pathology guidance to your repository request. Choose the work your study needs, from established IHC targets to further characterization of selected tissue.
THE INTEGRATED SERVICES APPROACH
Samples, services and pathology expertise through one partner
Repository samples
Selected for your study
- Fewer handoffs
- Spend less time coordinating samples and additional work across providers.
- Pathology-informed decisions
- Connect tissue suitability, assay selection and interpretation.
- Coordinated sample use
- Plan tissue allocation and laboratory work together, with one point of contact.
ASSAY LIBRARY & DEVELOPMENT
IHC assay library & development
Add protein biomarker measurements to your repository request with 100+ optimized IHC assays on Ventana and Dako platforms.
Our medical pathologists bring pharmaceutical industry experience to review and scoring. For targets outside the library, discuss assay development or transfer, with controls and scoring criteria agreed for your study.
Explore the assay libraryRNA IN SITU HYBRIDIZATION
RNAscope for spatial RNA expression
Locate target RNA within the tissue
Add RNA in situ hybridization to study target expression while retaining cellular and morphological context.
Explore RNAscope pre-qualified FFPE sections and TMAs, with control assessment and pathologist scoring.
Explore RNAscope servicesMULTIPLEX PROTEIN EXPRESSION
Multiplex immunofluorescence services
Connect protein markers, cells and clinical context
Study protein co-expression, immune-cell phenotypes and spatial relationships in tissue.
Start with clinically characterized FFPE tissue and TMAs, then plan multiplex staining, image analysis and pathology guidance around your study.
Explore multiplex IF servicesHBS & DONOR DATA
Quality biospecimens & data for precision medicine
UK · Italy · FranceDonors from participating medical centers, with informed consent and ethics approval.
FFPE surgical samplesPrimary tumors, metastases and normal (non-malignant) tissue.
Clinical and molecular records can inform cohort selection. Available fields vary by donor and collection.
Explore tissue cohortsEXTEND YOUR REPOSITORY REQUEST
Additional profiling and analysis
Discuss the additional measurements that would help answer your study question. Existing data and further laboratory work are reviewed separately.
NGS
Select tissue with existing molecular findings or discuss additional variant characterization for your chosen specimens.
Explore NGS & tissue profilingRNA-seq
Explore expression datasets associated with selected cohorts and options to add RNA profiling to repository tissue.
Explore RNA-seq & tissue dataSpatial profiling
Investigate protein and RNA patterns in tissue context, with clinically annotated FFPE sections and TMAs.
Explore spatial profilingDigital image analysis
Add quantitative measurements of biomarker expression and tissue distribution, supported by pathology review.
Explore image analysisWork with our experienced scientific team to tailor biospecimens, data, and integrated services to your research needs.
Our approach begins with our customers’ science.
We focus our acquisition on patient cohorts that meet the needs of biopharma, clinical, and translational researchers.
Plan your study
Discuss your repository and assay requirements
Tell us the tissue or cohort you need and any assays, profiling or pathology support you would like to add. We’ll review the relevant samples, existing data and additional work.